These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30611981)

  • 1. Theoretical study of the inhibition mechanism of human 20S proteasome by dihydroeponemycin.
    Serrano-Aparicio N; Świderek K; Moliner V
    Eur J Med Chem; 2019 Feb; 164():399-407. PubMed ID: 30611981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic and Electrostatic Effects on the Reaction Catalyzed by HIV-1 Protease.
    Krzemińska A; Moliner V; Świderek K
    J Am Chem Soc; 2016 Dec; 138(50):16283-16298. PubMed ID: 27935692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eponemycin exerts its antitumor effect through the inhibition of proteasome function.
    Meng L; Kwok BH; Sin N; Crews CM
    Cancer Res; 1999 Jun; 59(12):2798-801. PubMed ID: 10383134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent Inhibition of the
    Serrano-Aparicio N; Ferrer S; Świderek K
    Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundamental reaction pathway and free energy profile for inhibition of proteasome by Epoxomicin.
    Wei D; Lei B; Tang M; Zhan CG
    J Am Chem Soc; 2012 Jun; 134(25):10436-50. PubMed ID: 22697787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macyranones: Structure, Biosynthesis, and Binding Mode of an Unprecedented Epoxyketone that Targets the 20S Proteasome.
    Keller L; Plaza A; Dubiella C; Groll M; Kaiser M; Müller R
    J Am Chem Soc; 2015 Jul; 137(25):8121-30. PubMed ID: 26050527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic mechanism and product specificity of rubisco large subunit methyltransferase: QM/MM and MD investigations.
    Zhang X; Bruice TC
    Biochemistry; 2007 May; 46(18):5505-14. PubMed ID: 17429949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel non-covalent inhibitors selective to the β5-subunit of the human 20S proteasome.
    Xu K; Wang K; Yang Y; Yan DA; Huang L; Chen CH; Xiao Z
    Eur J Med Chem; 2015 Jun; 98():61-8. PubMed ID: 26005024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasome.
    Desvergne A; Genin E; Maréchal X; Gallastegui N; Dufau L; Richy N; Groll M; Vidal J; Reboud-Ravaux M
    J Med Chem; 2013 Apr; 56(8):3367-78. PubMed ID: 23540790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of solvent on nonenzymatic peptide bond formation mechanisms and kinetic isotope effects.
    Świderek K; Tuñón I; Martí S; Moliner V; Bertrán J
    J Am Chem Soc; 2013 Jun; 135(23):8708-19. PubMed ID: 23679067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Analyses of Substrate Preferences of 20S Proteasomes Using Peptidic Epoxyketone Inhibitors.
    Huber EM; de Bruin G; Heinemeyer W; Paniagua Soriano G; Overkleeft HS; Groll M
    J Am Chem Soc; 2015 Jun; 137(24):7835-42. PubMed ID: 26020686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantum mechanics/molecular mechanics studies of the mechanism of cysteine protease inhibition by peptidyl-2,3-epoxyketones.
    Arafet K; Ferrer S; González FV; Moliner V
    Phys Chem Chem Phys; 2017 May; 19(20):12740-12748. PubMed ID: 28480929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome inhibition by new dual warhead containing peptido vinyl sulfonyl fluorides.
    Brouwer AJ; Herrero Álvarez N; Ciaffoni A; van de Langemheen H; Liskamp RM
    Bioorg Med Chem; 2016 Aug; 24(16):3429-35. PubMed ID: 27316540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach.
    Groll M; Huber R
    Biochim Biophys Acta; 2004 Nov; 1695(1-3):33-44. PubMed ID: 15571807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic characterization of the chymotryptic activity of the 20S proteasome.
    Stein RL; Melandri F; Dick L
    Biochemistry; 1996 Apr; 35(13):3899-908. PubMed ID: 8672420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chaperone-driven proteasome assembly.
    Rosenzweig R; Glickman MH
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):807-12. PubMed ID: 18793141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of antibiotic resistance: QM/MM modeling of the acylation reaction of a class A beta-lactamase with benzylpenicillin.
    Hermann JC; Hensen C; Ridder L; Mulholland AJ; Höltje HD
    J Am Chem Soc; 2005 Mar; 127(12):4454-65. PubMed ID: 15783228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic mechanism of glycosyltransferases: hybrid quantum mechanical/molecular mechanical study of the inverting N-acetylglucosaminyltransferase I.
    Kozmon S; Tvaroska I
    J Am Chem Soc; 2006 Dec; 128(51):16921-7. PubMed ID: 17177443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fundamental reaction pathway and free energy profile of proteasome inhibition by syringolin A (SylA).
    Wei D; Tang M; Zhan CG
    Org Biomol Chem; 2015 Jun; 13(24):6857-65. PubMed ID: 26018983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Homosalinosporamide A and Its Mode of Proteasome Inhibition: An X-ray Crystallographic Study.
    Groll M; Nguyen H; Vellalath S; Romo D
    Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 30029468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.